Navigation Links
Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
Date:6/2/2008

Positive clinical outcomes showcased in poster presentations and satellite

symposium

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that eleven clinical posters detailing the clinical usage of its newly released MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey will be presented at the upcoming 3rd World Union of Wound Healing Societies (WUWHS) conference. This conference, being held in Toronto on June 5-9, takes place every four years and brings together the global thought leaders on advancements in wound care. Additionally, the company has announced that a one-hour satellite symposium will discuss the benefits of Active Leptospermum Honey and its role in advanced wound care.

Chairman and CEO Ed Quilty said, "The clinical outcomes evidence generated thus far for MEDIHONEY since the product's launch late last year has been exceptional. It is now becoming clear that the dressings are beginning to serve an important role as clinicians' first choice for wounds that have not progressed with standard care, making up roughly 50% of all chronic wounds. The eleven posters being presented at the WUWHS showcase the variety of wound types being treated successfully with MEDIHONEY. This evidence, combined with the satellite symposium, should have great impact on the conference attendees, and will contribute to the ramp up of global sales of the product."

The abstracts include the following:

1. "Active Leptospermum Honey Impregnated Calcium Alginate Dressing

Treatment Options for Medically Compromised Patients", Elizabeth Bodie

Gross, RN, NP, WCC.

2. "Wound Healing Experiences using a Honey Based Product", Mary Brennan,

RN, MBA, CWON, Long Island Jewish Medical Center.

3. "Active Leptospermum Honey Impregnated Calcium Alginate Wound
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Dermatologists Release Psoriasis Care Guidelines
2. Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the Worlds First Smart Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use
3. New Jersey Dermatologist Volunteers Show Golf Enthusiasts How to Play Safe in the Sun
4. Animal Dermatology Clinic Tustin Announces Dr. Russell Muses Appointment as the Member-At-Large for the Executive Board of the American College of Veterinary Dermatology
5. American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis
6. Womens Dermatologic Society Announces Collaboration on Americas Ethnic Skin: An Al Roker Health Special
7. Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
8. Derma Sciences MEDIHONEY(TM) Profiled By ABC News Philadelphia Affiliate
9. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
10. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, HealthShares(TM) Dermatology and Wound Care Index and HealthShares(TM) Orthopedic Repair Index
11. Dr. Lance H. Brown President-Elect of Dermatologic Society of Greater New York Fights Misconceptions About Sun Protection and Skin Care in Support of Skin Cancer Awareness Month - May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...cts highlights the cutting-edge of intraoperative ... Siemens Healthcare ( www.siemens.com/healt...ration ARCADIS(R) C-Arm systems, featuring outstan...nced precision in the OR, at the 94th Scientific A...iety of North America (RSNA) from November 30 to D...
(Date:12/1/2008)...ec. 1 An independent study at the,...n youngsters want to play,video games at the same...of,exercise. , Fifty children aged 11 and ...with video games provided by a company called Game...s only while they maintained movement on,the fitn...
(Date:12/1/2008)... Appear in Upcoming TV Commercial - , , CIN...g Expressions is "FanTaste-ic!" Crest Whitening Ex...ed the "What,s Your Catch Phrase?" contest in se...flavor experience of Crest Whitening Expressions t...cted from over 600 contest entries, and America vo...
(Date:12/1/2008)...Newswire/ -- One of America,s leading plastic,sur...ing technique for inner,vaginal lip reduction kno...tive. His study is published in the December 2008...he official medical journal of the American Societ... lip) reduction or labioplasty,is the most common...
Breaking Medicine News(10 mins):Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 2Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 3Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Video: America Votes Crest Whitening Expressions Is FanTaste-ic! 2Health News:Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful 2
... passion for cricket among South Asians to launch ...not to delay calling// emergency help when experie...s in Britain have a 40-50 per cent higher death ra... population. But South Asians are known to be relu...
... Dec ’05. The agenda would be to cut down the use ...ch as cookies, pastries and// other fast food. Th...pe that the board of health will have significantl...ng into consideration the concerns raised by 24,00...
... advice about chicken, which finds itself in the n...eria//, chicken seems to be hounded incessantly by...of 525 chickens, it found that nearly 83% of the c... campylobacter or salmonella bacteria, or both. Th...
...trexone may lessen cessation-related weight gain a... smoking appear //to benefit more than men. As a f...sts are focusing on gender differences in nicotine...rs Andrea King and her colleagues of the Universit...
Other Medicine News:Health News:British Heart Experts Use Cricket To Target South Asians 2
(Date:11/25/2008).... 25 Proteolix, Inc., a,leader in...cs that target,protein degradation pathways in ca...t data from two ongoing Phase 2 clinical trials of...d at the upcoming 50th Annual Meeting of the,Amer...the first in a new class,of specific proteasome i...
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...swire/ -- Domino,s Pizza (NYSE: DPZ ), the,reco...up to raise dough for,the kids of St. Jude Childr...anks and Giving campaign. Domino,s customers will ...of purchase to benefit the children of St. Jude.,... or when ordering online at, www.dominos.com . Th...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 1Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 2Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 3Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 4GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 1GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 2GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 3GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 4Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 1Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 2Acute Coronary Events Drop After Italys Public Smoking Ban 11909 1Acute Coronary Events Drop After Italys Public Smoking Ban 11909 2
...., April 17, 2007,/PRNewswire-FirstCall/ -- Cell G...rom two previously conducted Phase 2 clinical tria...uation of antibody,responses in patients with adva... the GVAX cell-based immunotherapy induces,antibod...ssociated,antigens, including some not previously ...
...-Apr 17, 2007 - A 9-month, randomized,double-blin...mparing a 40 mg dose of COPAXONE(R) given daily to...wed a 38 percent greater,reduction in inflammatory...e images (MRI) of the brain. In addition, patients...an on-trial relapse rate,of 77 percent when compar...
Other Medicine Technology:Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products: